Literature DB >> 1348366

Memory cell generation ablated by soluble protein antigen by means of effects on T- and B-lymphocyte compartments.

M Karvelas1, G J Nossal.   

Abstract

Adult C57BL/6 mice were injected with 100 micrograms of soluble, freshly deaggregated human serum albumin (HSA) to produce partial immunologic tolerance. Uninjected normal control (N) mice contain only approximately 100 B cells in their spleens with the capacity to (i) be activated in vitro into clonal proliferation by Escherichia coli lipopolysaccharide plus interleukins 2, 4, and 5, (ii) form IgG1 as well as IgM antibody, and (iii) display specificity for HSA when only IgG1 is allowed to score in an enzyme-linked immunosorbent assay (ELISA). Such N mice generate approximately 50,000 clonable anti-HSA IgG1 antibody-forming cell precursors in their spleens after T-dependent immunization with HSA absorbed onto alum and given with Bordetella pertussis adjuvant. Mice preinjected with soluble HSA (TOL) generate far fewer anti-HSA IgG1 antibody-forming cell precursors, termed anti-HSA memory cells. Splenocytes were transferred from N or TOL mice into lethally irradiated syngeneic recipients together with syngeneic bone marrow. Whereas N splenocytes generated plentiful memory cells within 2 weeks in antigenically challenged recipients, TOL splenocytes did not. Work with Ly-5 congenic mice ruled out memory cell generation from either the host or the bone marrow inoculum within this limited time. N T cells plus TOL B cells showed consistently lowered memory cell generation. TOL T cells plus N B cells showed an even greater lowering of adoptive memory cell generation. Thus the lowered response capacity of TOL mice resided in the T- and B-cell compartments. Attempts to show a suppressor component within the T-cell population were inconclusive, but a profound defect in capacity to respond to HSA in vitro was exhibited by the CD4+ T cells of TOL mice. B lymphocytes were harvested from T-dependently immunized mice 5 days after challenge, incubated with soluble HSA for 18 hr, and then adoptively transferred together with N T cells. The recently activated B cells were not rendered tolerant by this manipulation. The results argue for a major T-cell component in the process whereby soluble protein antigens ablate affinity maturation and memory cell generation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1348366      PMCID: PMC48822          DOI: 10.1073/pnas.89.7.3150

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

Review 1.  Transgenic mice as an in vivo model for self-reactivity.

Authors:  D A Ferrick; P S Ohashi; V A Wallace; M Schilham; T W Mak
Journal:  Immunol Rev       Date:  1990-12       Impact factor: 12.988

2.  Molecular characterization of single memory B cells.

Authors:  M G McHeyzer-Williams; G J Nossal; P A Lalor
Journal:  Nature       Date:  1991-04-11       Impact factor: 49.962

3.  Isolation and characterization of lymphokine cDNA clones encoding mouse and human IgA-enhancing factor and eosinophil colony-stimulating factor activities: relationship to interleukin 5.

Authors:  T Yokota; R L Coffman; H Hagiwara; D M Rennick; Y Takebe; K Yokota; L Gemmell; B Shrader; G Yang; P Meyerson
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

4.  Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes.

Authors:  D A Nemazee; K Bürki
Journal:  Nature       Date:  1989-02-09       Impact factor: 49.962

5.  Cellular sites of immunologic unresponsiveness.

Authors:  J M Chiller; G S Habicht; W O Weigle
Journal:  Proc Natl Acad Sci U S A       Date:  1970-03       Impact factor: 11.205

6.  Suppressor cells in transplantation tolerance. I. Analysis of the suppressor status of neonatally and adoptively tolerized rats.

Authors:  S Dorsch; B Roser
Journal:  Transplantation       Date:  1982-05       Impact factor: 4.939

7.  Single cell studies on the antibody-forming potential of fractionated, hapten-specific B lymphocytes.

Authors:  G J Nossal; B L Pike
Journal:  Immunology       Date:  1976-02       Impact factor: 7.397

8.  A role for suppressor T cells in induction of self-tolerance.

Authors:  J Gibson; A Basten; K Z Walker; R H Loblay
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

9.  Biological activity of recombinant human interleukin-2 produced in Escherichia coli.

Authors:  S A Rosenberg; E A Grimm; M McGrogan; M Doyle; E Kawasaki; K Koths; D F Mark
Journal:  Science       Date:  1984-03-30       Impact factor: 47.728

10.  A high-efficiency cloning system for single hapten-specific B lymphocytes that is suitable for assay of putative growth and differentiation factors.

Authors:  B L Pike; G J Nossal
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

View more
  5 in total

1.  Soluble antigen profoundly reduces memory B-cell numbers even when given after challenge immunization.

Authors:  G J Nossal; M Karvelas; B Pulendran
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

2.  Control of autoantibody affinity by selection against amino acid replacements in the complementarity-determining regions.

Authors:  M Børretzen; I Randen; E Zdárský; O Førre; J B Natvig; K M Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

3.  Peripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d I.

Authors:  T J Briner; M C Kuo; K M Keating; B L Rogers; J L Greenstein
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

Review 4.  Autoimmune tolerance and type 1 (insulin-dependent) diabetes mellitus.

Authors:  G J Nossal; K C Herold; C C Goodnow
Journal:  Diabetologia       Date:  1992-12       Impact factor: 10.122

5.  A disease-related rheumatoid factor autoantibody is not tolerized in a normal mouse: implications for the origins of autoantibodies in autoimmune disease.

Authors:  L G Hannum; D Ni; A M Haberman; M G Weigert; M J Shlomchik
Journal:  J Exp Med       Date:  1996-10-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.